Intervenção de Hugo Gonçalves Pereira no XIII Venture Capital IT
Intervenção de Hugo Gonçalves Pereira, ASK Ventures durante o XIII Venture Capital IT. http://www.gesventure.pt/vcit2013.
Intervenção de Hugo Gonçalves Pereira, ASK Ventures durante o XIII Venture Capital IT. http://www.gesventure.pt/vcit2013.
Wakefield, MA (PRWEB) January 23, 2014
TraceLink Inc., the leader in global pharmaceutical serialization, drug track and trace compliance and supply network performance solutions, announced today that life sciences industry veteran Michael Davies Ph.D. has joined the company as the Senior Vice President of Global Sales and Business Development.
Mike joins the TraceLink leadership team and will be responsible for shaping the company’s worldwide sales strategy and driving overall revenue generation. In addition, he is charged with building new business and channel partnerships to expand global market access for TraceLink’s cloud-based software application platform providing solutions for companies across the global life sciences supply chain.
“We are excited to have Mike join TraceLink and lead our global expansion in the life sciences supply chain,” said Shabbir Dahod, President and CEO of TraceLink. “His sales leadership, global experience and deep knowledge of the unique needs of the pharmaceutical industry further enhance the strong team we have built creating solutions that help the industry meet global regulatory compliance requirements and improve performance across the supply chain from ingredient to patient.”
“A major factor in my decision to join TraceLink is the company’s passion for tackling some of the biggest challenges facing the global pharmaceutical industry today: protecting patient safety, ensuring global track and trace compliance and improving access to global markets for needed medicines,” said Mike Davies, Senior Vice President of Global Sales and Business Development at TraceLink. “I am thrilled to have the opportunity to join a team so dedicated to this mission and I look forward to helping TraceLink grow its global business and build long-term customer relationships.”
With an eighteen year career in the biopharmaceutical industry, Mike has a proven track record of building and scaling sales organizations, developing markets and helping customers succeed at companies such as Oracle, Phase Forward and Parke-Davis (now Pfizer). As Vice President for Global Sales in the Health Sciences Global Business Unit at Oracle Corporation, he helped shape business unit strategy and led sales execution for Oracle’s Life Sciences and Healthcare solutions. At Phase Forward, Mike was instrumental in helping the company rapidly grow revenues by leading sales teams and designing and implementing channel partner programs for the company’s electronic data management and pharmacovigilance solutions. Mike started his career in various Life Sciences roles at Parke-Davis and Pfizer and he holds a Bachelor of Science degree from the University of Sunderland and a Ph.D. in Physiology & Pharmacology from the University of Bradford.
TraceLink serves the global life science industry through the TraceLink Life Sciences Cloud network platform, pharmaceutical track and trace solutions and supply network performance applications that help pharmaceutical companies and supply network partners connect, share key business data and collaborate across supply, production and distribution operations. Market leaders, including four of the top-10 pharmaceutical companies, use a single integrated connection to the TraceLink Life Sciences Cloud for:
Compliance with pharmaceutical serialization, product tracing and government reporting regulations for the US H.R. 3204 Drug Quality and Security Act, China, Brazil, Korea and other global drug track and trace regulations
Creation of a supply chain control tower that improves speed across external supply activities, increases visibility and control across the outsourced production lifecycle and enhances agility in meeting patient demand across global markets
To learn more about TraceLink’s scalable solutions serving pharmaceutical companies, CMO/CPOs, wholesale distributors and pharmacies of all sizes, complexities and locations across the globe, visit us at http://www.tracelink.com.
About TraceLink
TraceLink protects patients, enables health, grows profits and ensures compliance for companies across the global Life Sciences network through the TraceLink Life Sciences Cloud. The TraceLink Life Sciences Cloud is an Amazon AWS-based cloud application platform which enables complete global connectivity, visibility and traceability of pharmaceuticals from raw materials to patient. A single point and click connection to the Life Sciences Cloud delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. Winner of numerous industry awards including the Amazon AWS Global Start-Up Challenge Grand Prize and the Edison Award for Innovation in Health Management, the TraceLink Life Sciences Cloud is relied upon by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit http://www.tracelink.com or follow us on LinkedIn.
TraceLink is funded by FirstMark Capital. FirstMark Capital is an early stage venture capital firm based in New York City. Our mission is to partner with exceptional entrepreneurs who are changing the world by solving meaningful problems. We have built a deeply engaged community among the extraordinary teams in our network to spread ideas and opportunities. We are privileged to work alongside the founders of remarkable businesses like Pinterest, Lumosity, Aereo, TapAd, Shopify, Riot Games, and dozens more. Visit us in New York City or online at firstmarkcap.com and @FirstMarkCap.
Greeks who are not paying their tax bill will no longer have a choice. The country’s officials will now have the power to just go on ahead and take it from p…
Video Rating: 0 / 5
Oxford, Oxfordshire (PRWEB UK) 22 January 2014
A new methodology for estimating private equity returns has taken the guesswork out of analysing the ebb and flow of performance in this asset class, and suggests that these markets may be more volatile than was previously assumed. This could have a major impact on the decisions made by institutional investors such as, pension funds, endowments, colleges and foundations.
“The value of investments in listed companies is easy to measure. You just have to look at the share price,” said Ludovic Phalippou from Saïd Business School, University of Oxford, one of the academics involved in the project. “But valuing private equities has always been more a matter of opinion, a little more sophisticated than dinner party discussions about what people’s own houses are worth. Our methodology should change that.”
The methodology, developed by an international team of academics (Andrew Ang, Bingxu Chen, both at Columbia University, and Will Goetzmann at Yale University, together with Oxford’s Phalippou) has been designed to give investors and commentators a more accurate picture of the risks and returns of investing in private equities such as real estate, venture capital, buyout and debt. Instead of focusing on measures such as volume (commonly used to assess property markets and other private equity assets), and subjective valuations (commonly used in venture capital and buyout), Phalippou and the team have used only the actual cash flows paid and received by investors in different funds to estimate returns measured over time.
The result was an index demonstrating the dynamics of private equity between 1993 and 2011, which allowed the researchers to test theories about the cyclical nature of private equity returns.
“We found that the cycles shown in our index made sense when compared with commentary about the markets at the time,” said Phalippou. “However, they also revealed a greater degree of volatility within the overall cycle than standard industry indexes. For example, the volatility of our cash flow-based return time series for buyout funds is 25% per annum compared to 11% for the Cambridge Associates buyout index. Similarly, the NCREIF real estate index has a volatility of only 5%, while our estimated volatility of private real estate funds is 19%.”
Phalippou argues that the index shows that, over time, private equity investments do outperform a size-weighted index of listed companies. However, compared with the average listed company, and/or correcting for risk, “Returns are at par at best.”
For more information or to speak with Ludovic Phalippou please contact the press office:
Clare Fisher, Head of Public Relations, Saïd Business School
Mobile: +44 (0) 7912 771090; Tel: 01865 288968
Email: clare.fisher(at)sbs(dot)ox.ac.uk
Josie Powell, Press Officer, Saïd Business School
Mobile +44 (0)7711 387215, Tel: +44 (0) 1865 288403
Email: josie.powell(at)sbs(dot)ox.ac.uk or pressoffice(at)sbs(dot)ox.ac.uk
Notes to editors
About the paper
Estimating Private Equity Returns from Limited Partner Cash Flows
http://dx.doi.org/10.2139/ssrn.2356553
About Ludovic Phalippou
[http://www.sbs.ox.ac.uk/community/people/ludovic-phalippou
About Saïd Business School
Saïd Business School at the University of Oxford blends the best of new and old. We are a vibrant and innovative business school, but yet deeply embedded in an 800 year old world-class university. We create programmes and ideas that have global impact. We educate people for successful business careers, and as a community seek to tackle world-scale problems. We deliver cutting-edge programmes and ground-breaking research that transform individuals, organisations, business practice, and society. We seek to be a world-class business school community, embedded in a world-class University, tackling world-scale problems.
In the Financial Times European Business School ranking (Dec 2013) Saïd is ranked 12th. It is ranked 13th worldwide in the FT’s combined ranking of Executive Education programmes (May 2013) and 24th in the world in the FT ranking of MBA programmes (Jan 2013). The MBA is ranked 5th in Businessweek’s full time MBA ranking outside the USA (Nov 2012) and is ranked 5th among the top non-US Business Schools by Forbes magazine (Sep 2013). The Executive MBA is ranked 23rd worldwide in the FT’s ranking of EMBAs (Oct 2013). The Oxford MSc in Financial Economics is ranked 6th in the world in the FT ranking of Masters in Finance programmes (Jun 2013). In the UK university league tables it is ranked first of all UK universities for undergraduate business and management in The Guardian (Jun 2013) and has ranked first in nine of the last ten years in The Times (Sept 2013). For more information, see http://www.sbs.ox.ac.uk/
ENDS
Find More Venture Capital Press Releases
Max Keiser: If I could give Jamie Dimon a present for Christmas it would be syphilis. This week’s Venture Capital Christmas special features Max Keiser fro. …
Video Rating: 0 / 5
New York, NY (PRWEB) January 21, 2014
MonthlyExpress is undoubtedly the newcomer to the saturated subscription startup market. But Co-Founders Travis and Tara Loring have been quick to set their new service apart from other contenders since their launch in November of 2013. With boutique, hard-to-find, and most notably – full sized – products within their curated monthly collections, the service is more of a monthly indulgence than a subscription sample service like its competitors. The luxury experience caters to modern women with hectic lives. For the Founders, this dedication to delivering what MonthlyExpress calls “me time” to their female demographic has paid off. Just eleven weeks after their launch, the startup has completely sold out of their January collection.
But now’s not the time to stop and revel, says Co-Founder and CEO Travis Loring. “Our work is constantly evolving [to] discover and bring new products to our members… this is only the beginning of our journey.”
The Founders – both advertising and marketing executives in a previous life – center much of their company around the concept of “delivering happiness,” an industry term first coined by Zappos CEO, Tony Hsieh. Products from around the world are hand-selected for consideration for one of their monthly collections, and undergo a vigorous screening process before they are approved for inclusion in the exclusive service. Customer service calls and emails are returned the same day, and always by the Founders themselves. All this effort, says Loring, is to “ensure that our members are as delighted as we are about the products we curate and the experience we provide. The level of experience we offer our members is – I’m confident – why women respond to our service.”
Loring and Loring also attribute much of this their early success to “simply following what [they] know” and “addressing a need that [they] experience[d] firsthand”. It appears women around the country would agree. Memberships are continuing to roll in despite several notes on their website that new members will only begin in February.
The startup has not been without its challenges. As with any startup, minimal capital was, and continues to be a concern. The Founders started the company with their own savings. MonthlyExpress is not venture-backed and currently has no plans to pitch for venture capital funding in the near future, but the Founders have stated that they are “evaluating all of [their] growth options.”
“We’re very much aware of the opportunities for expansion,” says Co-Founder and COO Tara Loring, “but what’s most important to us right now is continuing to deliver a luxury experience to our members that no other monthly service does. I’m confident that’s why we’ve had such tremendous response. So we’re going to keep on doing it.”
About MonthlyExpress
MonthlyExpress is a membership-based subscription service offering luxurious parcels of nourishing, boutique products, delivered monthly to your door. Members discover master-crafted, hard-to-find, and even limited-supply high-end products from shops and brands all over the globe with each shipment. MonthlyExpress is a way to savor replenishing moments of ME time, any time. These carefully curated and finely crafted collections also make for the perfect gifts for the haute hostess, an appreciated colleague, or a special lady. For more information or to sign up for a membership, visit MonthlyExpress online at http://www.monthlyexpress.com. They can be found on Facebook at http://www.facebook.com/monthlyexpress and on Twitter at @MonthlyExpress.
Related Venture Capital Press Releases
Los Angeles, CA (PRWEB) January 17, 2014
A rapidly growing number of start-up and expanding business owners are skipping traditional bank loans and venture capitalists for a faster and cheaper financing alternative, called the EB5 Visa Direct Investment program. “This direct or stand-alone program is literally on fire,” said Bernard Wolfsdorf of Wolfsdorf Immigration Law.
It connects wealthy overseas investors who want a green card with regional business owners who need money to grow and expand. Southern California CEO Magazine talked with leading Securities and immigration attorneys and investment consultants about this hot new trend at a recent EB5 Summit in Los Angeles.
The EB5 Visa Investment program was created by Congress in 1990 to stimulate U.S. economic growth by job creation through capital investment by foreign investors. An investment made by an immigrant must create at least 10 new American jobs over a period of at least two years. If successful, the investor receives their permanent green card. The U.S. Citizenship and Immigration Services sets aside up to 10,000 visas for immigrants willing to invest at least $ 500,000 or more to create these new jobs in American businesses.
Almost all EB5 investment has been in massive Regional Center Projects which involve hundreds of foreign investors and scores of millions of dollars. The projects have been complicated, and it has been difficult to determine how many American jobs each foreign investor has created. Many of the investors have also profited little or lost money. But, that has changed over the last year.
“More investors are finally realizing that there is opportunity with direct investment, “said Brian Su of the Artisan Business Group. Su primarily helps U.S. companies connect with cash-flush investors in China who want more control on the projects they back, but, they don’t necessarily seek as much equity in the business as a venture capitalist would likely demand.
As long as the project is very strong and the business is good, Su’s investors are willing to risk their money. “They’re not looking for tremendous returns,” Su said. “They’re just looking for legal residency through the EB5 program.”
The pool of investors has also quickly expanded from China, to include entrepreneurs from Brazil, Chile, India, Korea, South Africa and Vietnam. Up to 20% of all EB5 investment now directly benefits the little guy.
“The smaller business that’s looking to add 10 or 20 or 30 people onto their payroll, they can tap into this financing source, and the cost of doing so is less than half of the cost of big projects. So, it’s something the smaller business can afford in order to enlarge their business or start their business from a dead stop,” said Michael Michael Homeier of Homeier and Law. “It’s very exciting.”
The EB5 Visa Direct Investment program can also help small business get cash fast and with less hassle than standard bank loans or venture capital deals.
“This is the big winner,” said immigration attorney Bernard Wolfsdorf. “We’re talking two to three months. That’s how quickly the money can flow in to the job creating enterprise. You don’t have all this massive apparatus, and complicated framework. You basically put together a business plan. You outline the structure. You show where it’s going to go. You raise the money and the money starts coming in within months.”
The EB5 Visa Direct Investment program has also become powerful economic stimulus tool for Southern California cities and counties.
“Jobs create jobs,” said Kevin Wright of Wright Johnson, LLC. The EB5 program consultant said investors bring capital into a county or city. That creates more jobs, which creates more tax revenue, which creates more direct and indirect jobs, and in turn, more tax revenue. “So, it really helps to perpetuate an entire community through these investments,” Wright said.
The EB5 Visa Direct Investment program is a real opportunity for a lot of U.S. businesses and local governments to get back on their feet, said immigration attorney Michael Homeier. Businesses are struggling to get capital, and there is a huge wave of wealthy people overseas willing to put their money at risk on a U.S. business to create jobs and to get a green card. “That’s a perfect storm,” he said.
Find More Venture Capital Press Releases
(PRWEB) January 18, 2014
Adam Paul Green, an Austin Texas G3 Chocolatier Journal, is pleased to reports that Seattle Food Scientist, Terry Wakefield, has just completed a comprehensive fact analysis of MXI Corp; Xocai Healthy Cacao.
Modern food scientists and technologists are versatile, interdisciplinary and collaborative practitioners in a profession at the crossroads of scientific and technological developments. As our food system has drastically changed, from one centered around family food production and preservation on individual farms to the modern system of today, most people are no longer connected to their food nor are they familiar with the agricultural production and food manufacturing processes designed for providing higher quality, safe food. In the United States, food science is typically studied at “land-grant” universities which were chartered in the mid-1800’s to support agricultural and technical education.
Terry Wakefield quote: “In my case, I went to school at Oregon State University located in Corvallis, Oregon. A food science and engineering curriculum is an eclectic mix of “hard” and “soft” science — chemistry, biology, economics, microbiology, statistics, nutrition and engineering blended together with the culinary arts. Upon my graduation, I went to work for General Foods (currently part of Kraft) as a quality control supervisor. I quickly moved into a plant quality control manager position and then on into corporate quality assurance where I was responsible for helping assure that all of the company’s production facilities met standards and that key ingredient suppliers were in compliance with specifications. I was then promoted to quality control manager of a large plant where I was also on the original product development and commercialization team for Cool Whip.”
http://oregonstate.edu/foodsci/
VIDEO:
Discovery IFT Food Science
http://www.dailymotion.com/video/x9gnzr_discovery-ift-food-science_shortfilms
“My next assignment was in Delaware as quality control manager for a 27 acre production facility which produced a broad array of products (Minute Rice, Minute Tapioca, Baker’s Coconut, Log Cabin Syrup, Dream Whip, Kool-Aid, Jell-O Gelatin & Pudding, Stove Top Stuffing and Baker’s Chocolate). With chocolate back in my life, I was able to transition out of the quality control arena and into production management. I was responsible for producing most of the products noted above, but my favorite assignment was running the 6.5 acre chocolate manufacturing facility. We had 40 silos (each held 1 million pounds) for storing cocoa beans so I had access to beans from virtually every part of the world (Madagascar, Bahia, Sanchez, Samoa, Ghana, Maracaibo, Arriba, etc.). I have also had a privilege to work for Bissinger’s Handcrafted Chocolates in St. Louis as Senior VP and Chief Chocolatier. This very old chocolate company had originally made chocolate for King Louis XIV,” says Terry Wakefield.
Thanks to a new friend, Adam Green, Terry Wakefield discovered “Xocai” and became intrigued.
Terry Wakefield
terryw934(at)gmail(dot)com
http://cacaopow.youthfulchocolate.com/
About Us
G3 Development is set out to proactively serve the business community by providing solutions in entrepreneurialism, business development, social media and venture capitalism.
To provide leadership in establishing strength with our client’s international businesses, being built on a foundation of innovation, advocacy, technology and business integrity
http://www.g3-development.co/
1-877-229-9183
news,abc,barack obama,fox news,song,cnn news today,abc news,cnn news,chris brown interview,tv bloopers,nbc news,cbs news,abc news special report,abc news tod…
Video Rating: 0 / 5